Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy – GenomeWeb
NMSU Herald |
Illumina, Bristol-Myers Squibb Partner on Companion Dx Development for Immunotherapy
GenomeWeb "Through our deep understanding of cancer biology and emerging research, we recognize the importance for physicians to know each patient's biomarker status to help fight their cancer in a more personalized way," Saurabh Saha, senior vice president … Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion … Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo |
